The newest generation of antiobesity medications (AOMs)—GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), dual action GLP-1/GIP combinations, triple action injectables, and emerging injectable and oral medications—have changed the landscape for weight management, bringing weight loss success to many for whom weight maintenance had previously not been possible.
Weight Management
Metabolic syndrome (MetS) is a collection of disorders that include abdominal obesity, hypertension (HTN), dyslipidemia including high triglycerides (TGs) and/or low HDL cholesterol, and impaired glucose metabolism (elevated fasting blood glucose).
The Intuitive Eating (IE) framework, developed by two RDs three decades ago, is based on 10 principles designed to foster attunement to internal physical sensations, thereby supporting biological, including psychological, needs.
Artificial sweeteners, also called alternative, nonnutritive, and low- or no-calorie sweeteners, are a popular ingredient in many foods and beverages.
Traditional weight loss recommendations encourage people to eat less and move more to create a calorie deficit, leading some people to believe that the more they restrict their food intake, the more weight they’ll lose.
Obesity in childhood has been a major topic and health concern in this country for decades.
Today’s DietitianVol. 26 No. 1 P. 24 According to the CDC’s 2022 US obesity prevalence statistics, the rate of adult…
Today’s DietitianVol. 25 No. 9 P. 24 Patient Care and Counseling Guidance for RDs Obesity management is at an inflection…
Today’s DietitianVol. 25 No. 2 P. 10 Dietitians have heard the dire statistics before. The prevalence of obesity in the…
Suggested CDR Performance Indicators 8.1.2, 8.1.5, 9.1.3CPE Level 2 Take this course and earn 2 CEUs on our Continuing Education…